EGFR and head and neck cancer: Dysregulation of EGFR signaling through overexpression of the receptor or hyper-activation of its kinase activity is a common theme in several solid tumors including non-small cell lung cancer (NSCLC), head and neck cancer (HNSCC), colorectal cancer, breast cancer and glioblastoma multiforme.